Magnetic resonance imaging versus musculoskeletal ultrasonography in detecting inflammatory arthropathy in systemic sclerosis patients with hand arthralgia by unknown
ORIGINAL ARTICLE
Magnetic resonance imaging versus musculoskeletal
ultrasonography in detecting inflammatory arthropathy
in systemic sclerosis patients with hand arthralgia
Rasha A. Abdel-Magied • A. Lotfi • Ehab A. AbdelGawad
Received: 8 April 2012 / Accepted: 4 January 2013 / Published online: 25 January 2013
 The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract The aim of the study was the detection of
inflammatory arthropathy in patients with systemic scle-
rosis (SSc) with arthralgia using musculoskeletal ultraso-
nography (MSUS) and magnetic resonance imaging (MRI)
and to compare between MRI versus MSUS detecting
musculoskeletal abnormalities and find out its relation with
other clinical and laboratory parameters. Sixteen SSc
patients with hand arthralgia had a baseline MSUS for their
hands. Six months later, patients had a second MSUS and
MRI with gadolinium of their most symptomatic hand. Of
the 16 patients examined by MSUS, it was found that on
baseline and second examination, tenosynovitis was seen in
8 (50 %) and 7 (43.7 %) patients and synovitis was seen in
4 (25 %) and 5 (31 %) patients, respectively, indicating
persistence synovial inflammation, and erosion was seen in
only 1 (6.3 %) patient on baseline and second examination.
Regarding MRI, 81.3 % (13) patients had tenosynovitis,
87.5 % (14) patients had synovitis, and 62.5 % (10)
patients had erosions. Applying the RAMRIS system (a
semiquantitative MRI scoring system used in RA), the
mean values for synovitis, bone marrow edema, and ero-
sions fell within the range seen in RA. Systemic sclerosis
patients with arthralgia that have no obvious clinical
inflammatory arthritis were found to have persistent
inflammatory erosive arthropathy in their hands and wrists
using MSUS and MRI. While both MRI and MSUS are
useful in characterizing synovial inflammation in SSc, MRI
is clearly more sensitive than MSUS in this setting. Further
studies on larger number of SSc patients with arthralgia
and a control group consisting of SSc patients without
arthralgia to better establish the clinical and radiological
findings in SSc.
Keywords Scleroderma  Hand arthralgia  MSUS  MRI
Abbreviations
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Systemic sclerosis (SSc; scleroderma) is a chronic disorder
of connective tissue characterized by inflammation, fibro-
sis, and degenerative changes in the blood vessels, skin,
synovium, skeletal muscle, and multiple internal organs.
The clinical features, organ system involvement, natural
history, and survival among patients with SSc are highly
variable and largely depend on SSc clinical subtype and
SSc-associated serum autoantibodies [1]. The musculo-
skeletal findings in progressive systemic sclerosis have
been the subject of continued controversy, partly because
most reports describe mixed populations of SSc, mixed
connective tissue disease (MCTD), overlap syndromes of
several connective tissue diseases and calcinosis,
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Raynaud’s phenomenon, esophageal dysmotility, sclero-
dactyly, and telangiectasia (CREST) patients [2].
Generalized arthralgia and morning stiffness are typical
symptoms of systemic sclerosis and may be confused with
early RA [3]. Although arthralgia is common in SSc, its
cause is poorly understood. It is usually attributed to
mechanical factors resulting from fibrosis, with tendon
friction [4]. Clinically appreciable joint inflammation is
uncommon, although erosive arthropathy has been dem-
onstrated to occur in some series in as many as 29 % of
patients. Inflammatory and fibrinous involvement of tendon
sheaths may mimic arthritis [3].
Erosive changes have been reported on X-rays in some
SSc patients [5] and have been attributed to overlap with
mixed CTD [6] or RA.
Musculoskeletal ultrasonography (MSUS) is used in the
assessment of patients with inflammatory arthritis. This
includes the detection of bone erosions, synovitis, and
tendon disease. MSUS has a number of distinct advantages
over magnetic resonance imaging (MRI), including its
ability to scan multiple joints in a brief period of time and
patient tolerability. MSUS, however, is often perceived as
an imperfect and operator-dependent tool [7]; however,
MRI is superior to MSUS in detection of inflammatory
arthritis [4, 8, 9].
Musculoskeletal ultrasonography and MRI can identify
and characterize subclinical synovial inflammation and joint
damage with much greater precision than X-rays [8, 9].
Patients and methods
Twenty patients meeting ACR classification criteria for
SSc [10] without clinical features of overlap syndromes or
MCTD were screened for arthralgia.
Patients with scleroderma/RA overlap or patients with
MCTD were excluded from the study.
All the twenty patients underwent musculoskeletal
examination and laboratory tests in the form of RF and
anti-CCP antibodies. At the time of the start of the study,
patients with swollen joints (clinical arthritis) and/or
positive RF and/or positive anti-CCP serology were
excluded to allow a reasonable assumption that our patients
did not include patients with clinically or laboratory RA
overlap.
Of these 20 patients who reported arthralgia, four
patients were excluded from the study [2 patients had
clinical arthritis (swollen joints) and positive anti-CCP
antibodies, and the other 2 patients had positive RF]. After
exclusion of those 4 patients, 16 patients were participated
who were both RF and anti-CCP negative and did not have
clinical arthritis. All patients participating in the study
provided written informed consent.
All patients had detailed history (including age, sex, and
disease duration) and a full clinical assessment of skin
involvement and the musculoskeletal system. All patients
had arthralgia, but none had any symptoms or signs of
inflammatory arthritis (patients who had arthritis were
excluded from the study). Laboratory evaluation including
ESR, CRP, ANA, and anti-RNP was performed for all the
patients.
Plain X-ray of both hands and wrists was done for all the
studied patients.
Musculoskeletal ultrasonography evaluation was per-
formed using Picus 4D GE Vivid-3 Expert machines, with
7.5–12 MHz phased-array transducer. Two rheumatolo-
gists experienced in MSUS sequentially performed scans of
both wrists and hands assessing joints (radiocarpal, inter-
carpal, MCP, PIP, and DIP) and tendons (all extensor and
flexors of the fingers at the level of the wrists) using a
multiplanar and dynamic scanning technique according to
standard ultrasonographic scans proposed by the EULAR
working group for MSUS in rheumatology [11].
All explored joints and tendons were evaluated for the
presence of synovial inflammation and synovial hypertro-
phy on grayscale and synovitis/tenosynovitis on power
Doppler ultrasonography (PDUS) signal according to
OMERACT definitions criteria [7]. The presence of syno-
vitis/tenosynovitis on grayscale and PDUS signal sug-
gested synovial inflammation on MSUS, as per previously
published guidelines [12].
All the 16 patients had a second MSUS of both hands
after a 6-month interval performed by the same sonogra-
phists to look for persistence of synovial inflammation.
All the 16 patients had MRI scan with IV gadolinium
contrast of their most symptomatic hand and wrist, within
the same week of having the second MSUS. MRI was
performed with a 1 T Magnet (Intera, Philips Medical
Systems, Neberland B.V) with dedicated peripheral coils.
IV gadolinium was used (Dotarem 0.5 mmol/ml). The
following sequences were acquired: T1 weighted (TR 500,
TE20, FOV 110 mm, Matrix 304, slice thickness 2.5 mm),
fast spin-echo PD-weighted (TR 1800, TE37, FOV 110,
Matrix 304, slice thickness 2.5 mm), and fat-suppressed
images (TR 3500, TE 55, FOV 130, Matrix 272, slice
thickness 3 mm).
MRI images were assessed by a musculoskeletal radi-
ologist (blinded to the ultrasound findings) for the presence
of synovitis, tenosynovitis, bone marrow edema, and ero-
sions. Images were scored using the scoring system for
synovitis, erosions, and bone marrow edema, used to score
MRI scans in RA (RAMRIS) [13].
Statistical analysis was performed using SPSS for
Windows version 17.0, two-tailed tests were used
throughout, and statistical significance was set at \0.05
levels.
1962 Rheumatol Int (2013) 33:1961–1966
123
The following statistics were carried out: Descriptive
statistics of the range, means, and standard deviation were
calculated for interval and ordinary variables and frequen-
cies and percentages for categorical variables, correlations
(bivariate correlations procedure computes Pearson’s
correlation coefficient with its significance levels), and
percentage of agreement.
Results
Patients’ demographics and disease characteristics
Of the 16 patients involved in the study, there were 11
(68.8 %) with limited SSc and 5 (12.5 %) had diffuse SSc.
There were 2 (12.5 %) males and 14 (87.5 %) females.
Their mean age was 40.6 years (range 20–63 years), and
their mean disease duration was 5.4 years (range
1–15 years). Among the 16 patients, CRP was positive in
11 (68.8 %) patients, ANA in 5 (93.7 %) patients, and anti-
RNP in 2 (12.5 %) patients. All patients were RF and anti-
CCP negative. The patient demographics and disease
characteristics are presented in Table 1.
Plain radiography of both hands and wrists did not show
any evidence of erosions.
MSUS findings
At the baseline examination, tenosynovitis was present in 8
(50 %) out of 16 patients, synovitis was present in 4 (25 %)
patients, and erosions were found in only 1 (6.3 %) patient.
On the second MSUS examination after 6 months, teno-
synovitis was present in 7 (43.8 %) out of 16 patients,
synovitis was present in 5 (31.3 %) patients, and erosions
were found in only 1 (6.3 %) patient (Fig. 1).
MRI findings
Of the 16 patients examined by MRI on the same week
with the second MSUS examination, tenosynovitis was
present in 13 (81.3 %) out of 16 patients, synovitis
was present in 14 (87.5 %) patients, bone marrow edema
was present in 12 (75 %) patients, and erosions were found
in 10 (62.5 %) patients (Fig. 1).
MSUS findings (tenosynovitis, synovitis, and erosion)
and MRI findings (tenosynovitis, synovitis, erosion, and
bone marrow edema) are presented in Table 2.
Percentage of agreement between the findings of MSUS
and MRI is presented in Table 3.
RAMRIS scores
The RAMRIS score for synovitis was 12.9 (range 8–19),
for edema was 3.8 (range 1–8), and for erosions was 10.2
(range 4–16).
Disease characteristics and synovial inflammation
There was significant correlation between disease duration,
patients’ age, and MRI erosions (p = 0.001 and p = 0.01),
respectively.
Also, significant correlation found between MSUS
tenosynovitis and CRP (p = 0.04).
There were significant correlations between the CRP and
the MRI tenosynovitis, MRI synovitis, and bone marrow
edema (p = 0.002, p = 0.02, and p = 0.03), respectively.
RAMRIS synovitis score was significantly correlated with
ESR (p = 0.3) and RAMRIS erosion score was significantly
correlated with MRI findings of erosions and bone marrow
edema (p = 0.004 and p = 0.04), respectively.
Disease subtype and antibody status did not have any
significant relation to inflammation seen on MRI or MSUS
or erosions.
Discussion
Musculoskeletal findings in SSc have been the subject
of continued controversy, partly because most reports
Table 1 Patients’ demographics and disease characteristics of the
studied patients
Range Mean ± SD
Age (years) 20–63 40.6 ± 12.1
Disease duration (years) 1–15 5.4 ± 3.6
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describe mixed populations of PSS, mixed connective tis-
sue disease (MCTD), and overlap syndromes of several
connective tissue diseases [2].
Generalized arthralgia and morning stiffness are typical
symptoms of systemic sclerosis and may be confused with
early RA [3]. Erosive changes have been reported on
X-rays in some SSc patients [5] and have been attributed to
overlap with RA or MCTD [6].
In this study, we use MSUS and MRI to search for
evidence of an inflammatory arthropathy in a group of
SSc patients with arthralgia without clinical evidence of
inflammatory arthritis and without an overlap with RA
or patients with MCTD.
Although in our study, patients with positive RF and/or
anti-CCP were excluded; there were 2/20 (10 %) patients
who were RF positive and another 2/20 (10 %) patients
who were anti-CCP positive, and those patients were
excluded to allow a reasonable assumption that our patients
did not include patients with clinically apparent RA over-
lap. However, Santiago et al. [14] found that the frequency
of anti-CCP2 antibodies in SSc was 14.8 %. Varga and
Denton [3] confirmed that RF positivity may be found in up
to 30 % of patients with SSc.
In our study, anti-RNP was positive in 2/16 (12.5 %)
patients; however, it did not have any significant relation to
inflammation seen on MRI or MSUS or erosions. In
agreement with these findings, Chitale et al. [4], who found
anti-RNP antibody positive in 2/17 (14 %) patients and the
antibody did not have any significant relation to inflam-
mation seen on MRI or MSUS. Also, Varga and Denton [3]
confirmed that about 20 % of patients with SSc have
antibody directed against nuclear ribonucleoprotein (anti-
RNP).
In our study, plain radiographic examination of both
hands and wrists did not confirm the presence of erosive




Fig. 1 Imaging evidence of synovitis, tenosynovitis, and erosion.
a Coronal STIR image shows an abnormal marrow signal involving
the lunate bone (long arrow), also a hyperintense signal also seen
partially affecting the scaphoid and the inner aspect of the radius
denoting bone marrow edema (short arrows). b Coronal MRI image
in a different patient shows erosive changes affecting the base of the
4th metacarpal bone (arrows). c Coronal T2 image shows erosive
changes and marrow edema affecting the scaphoid bone (arrow).
d MSUS image of bone erosion on longitudinal and transverse scan
(arrow). e Longitudinal ultrasonographic view of MCP joint depicting
grayscale synovial hypertrophy and synovitis (asterisk). f A trans-
verse ultrasonographic view of the common extensor tendon at the
level of the wrist showing grayscale tenosynovitis in the form of
effusion (arrow)






Number (%) Number (%) Number (%)
Tenosynovitis 8 (50) 7 (43.8) 13 (81.3)
Synovitis 4 (25) 5 (31.3) 14 (87.5)
Erosions 1 (6.3) 1 (6.3) 10 (62.5)
BME
(for MRI)
– – 12 (75)
Table 3 Percentage of agreement between the findings of MSUS and
MRI
Tenosynovitis Synovitis Erosion
MSUS (n = 16) 7 5 1
MRI (n = 16) 13 14 10
Percentage of agreement 62.5 43.8 43.8
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inflammation is usually low grade and is replaced by
fibrosis at some stage [4]. However, Sari-Kouzel et al. [5]
confirm the presence of erosions in hands and feet joints of
SSc patients as seen on X-ray (with or without overlap
syndrome), but synovitis has been little studied [4].
Chitale et al. [4] were the first to use MSUS to detect
synovial inflammation and confirm its persistent nature in
patients with SSc, and then, they compare their results with
MRI.
In our study, we found the evidence of an inflammatory
arthropathy in a group of SSc patients with arthralgia
without clinical evidence of inflammatory arthritis using
MSUS and MRI.
In agreement with these findings, Rodnan [15] reported
that SSc patients had inflammatory changes in the syno-
vium on biopsies. Schumacher [16] reported fibrin depo-
sition and mild focal proliferation of synovial lining cells,
with perivascular infiltration of lymphocytes and plasma
cells in a proportion of SSc patients, further supporting
evidence of synovial inflammation. Misra et al. [17] char-
acterize the arthritis in a group of 34 SSc patients and
identified synovitis in 88 %. Bourty et al. [18] reported
mild inflammatory changes in the joints of SSc patients on
MRI scan.
Low et al. [19] reported more inflammatory changes on
MRI, in a significant proportion of their symptomatic SSc
patients. However, their study cohort included patients
with clinically swollen joints and positive serology for RF
suggesting inclusion of patients with features of RA
overlap.
In our study, at the baseline examination, tenosynovitis
was present in 8 (50 %) out of 16 patients and synovitis
was present in 4 (25 %) patients. On the second MSUS
examination after 6 months, tenosynovitis was present in 7
(43.8 %) out of 16 patients and synovitis was present in 5
(31.3 %) patients that indicate the presence and persistence
of inflammatory arthropathy.
In agreement with these findings, Chitale et al. [4] found
that MSUS identified inflammation in a high proportion of
patients: Tenosynovitis was more common and seen in 8
(47 %) of the 17 and 6 (46 %) of the 13 patients at baseline
and second MSUS, respectively, than synovitis, which was
identified in 1 (6 %) of the 17 and 3 (23 %) of the 13
patients at baseline and second MSUS, respectively. There
was 70 % agreement for detection of synovial inflamma-
tion between baseline and second MSUS [expected
agreement 50 %, (p = 0.06)], suggesting that inflamma-
tory joint disease and tendinopathy were persistent in many
patients.
In our study, of the 16 patients examined by MRI on the
same week with the second MSUS examination, tenosyn-
ovitis was present in 13 (81.3 %) out of 16, synovitis was
present in 14 (87.5 %), and bone marrow edema was
present in 12 (75 %) patients. MRI proved to be much
more sensitive in detecting synovial inflammation than
MSUS in our study.
In agreement with these findings, Chitale et al. [4] found
that tenosynovitis was present in 7 (88 %) of the 8 patients
and bone marrow edema was seen in 63 % of patients.
However, they found synovitis in 100 % of the patients, but
this may be due to the fact that MRI was done for only 8/17
patients in their study who had signs of synovial inflam-
mation on MSUS examination, but in our study, MRI was
done for all patients with or without signs of synovial
inflammation on MSUS examination.
In our study, MSUS confirms the erosive nature of this
inflammatory arthropathy in one patient only; however,
MRI confirms the erosive nature of this arthropathy in large
proportion of the studied group. At the baseline examina-
tion, erosions were found in only 1 (6.3 %) patient. On the
second MSUS examination after 6 months, erosions were
also found in only 1 (6.3 %) patient. On MRI examination,
erosions were found in 10 (62.5 %) patients. MRI proved
to be much more sensitive in detecting erosions than
MSUS in our study.
In agreement with these findings, Chitale et al. [4] found
erosions in 6 (75 %) of the 8 patients on MRI examination;
however, in their study, MSUS failed to identify any ero-
sion at either baseline or on second MSUS, and so they
proved that MRI was more sensitive in detecting erosions
than MSUS in our study.
In our study, the percentage of agreement between
MSUS and MRI for the detection of tenosynovitis, syno-
vitis, and erosion was 62.5, 43.8, and 43.8, respectively.
These results were comparable with a degree of agreement
with Chitale et al. [4] who found that the degree of
agreement between MSUS and MRI for the examined
parameters (tenosynovitis, synovitis, and erosion) was 62,
38, and 25, respectively.
In our study, the RAMRIS score for synovitis was 12.9
(range 8–19), for edema was 3.8 (1–8), and for erosions
was 10.2 (range 4–16). This mean RAMRIS scores in our
study fall within the range of scores obtained from early
[20, 21] and established [22] RA.
In agreement with these findings, Chitale et al. [4] found
that the RAMRIS score for synovitis was 12.6 [interquar-
tile range (IQR) 8.6–16.7], for edema was 3.4 (IQR
0.19–6.6), and for erosions was 9.75 (IQR 2.8–16.7). So
they suggested that the extent of the synovitis, bone mar-
row edema, and erosions may not be dissimilar between
RA and the selected studied group of SSc patients.
Our study has a number of limitations. This is a small
study and includes only 16 patients with SSc with varied
disease duration. Also, only symptomatic patients with
arthralgia were included in the study. We recommend that
further studies can be done involving larger number of
Rheumatol Int (2013) 33:1961–1966 1965
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patients and a control group consisting of SSc patients
without arthralgia.
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